Prevalence of latent tuberculosis infection in Sudan: A case-control study comparing interferon-γ release assay and tuberculin skin test

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Shakak, Amani Osman ^a   Khalil, Eltahir Awad Gasim ^b,g   Musa, Ahmed Mudawi ^b   Salih, Kawthar Abd Eljalil Mohamed ^c   Bashir, Abd Elgadir Ali ^d   Ahmed, Ala Hassan ^e   Idris, Fath Elrahman Mohamed ^f   Elhassan, Ahmed Mohamed ^b  

^a University of Shendi   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c Elneil College of Medicine   (Sudan)

^d FEDERAL MINISTRY OF HEALTH   (Sudan)

^e UNIVERSITY OF KHARTOUM   (Sudan)

^f Khartoum North Teaching Hospital   (Sudan)

^g MINISTRY OF SCIENCE AND TECHNOLOGY   (Sudan)

Author keywords

Contact tracing; IFN release assay; Latent Tb infection; Sudan; TST

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; PREVALENCE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARD; SUDAN; TUBERCULIN TEST;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; PREVALENCE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUDAN; TUBERCULIN TEST;

EID: 84889073927     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-1128     Document Type: Article

References (34)

1. WHO Report, Global Tuberculosis Control 2010 WHO/HTM/TB/2010.7
2. Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Machado A, Emodi K, Takenami I, Finkmoore BC, Barbosa T, Carvalho J, Cavalcanti L, Santos G, Tavares M, Mota M, Barreto F, Reis MG, Arruda S, Riley LW, IJTLD 2009 13 446 453
3. The tuberculin skin test. Huebner RE, Schein MF, Bass JB Jr, Clin Infect Dis 1993 17 968 975 10.1093/clinids/17.6.968 8110954 (Pubitemid 23358739)
4. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Pai M, Zwerling A, Menzies D, Ann Intern Med 2008 149 177 184 10.7326/0003-4819-149-3-200808050-00241 18593687
5. Peripheral T cell IFN-gamma responses and latent tuberculosis. Dheda K, Rook G, Zumla A, Am J Respir Crit Care Med 2004 170 97 98
6. Interferon-gamma release assay (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics. Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. Barth RE, Mudrikova T, Hoepelman AIM, Int J Infect Dis 2008 12 1 6
7. Possible risk factors of progression to overt disease among individuals with latent tuberculosis infection in the Sudan. Shakak AO, Khalil EAG, Musa AM, Salih KAM, Bashir AA, Ahmed AH, Idris FM, Elhassan AM, IJCR 2013 5 1107 1110
8. Timing dose of BCG vaccination in infants as assessed by post vaccination tuberculin sensitivity. Aggarwal A, Dutta AK, Indian J pediatr 1995 32 35 39
9. A coefficient of agreement for nominal scales. Cohen J, Educ Psychol Meas 1960 20 37 46 10.1177/001316446002000104
10. Controlled chemoprophylaxis trials in tuberculosis. A general review. Ferebee SH, Bibl Tuberc 1970 26 28 106 4903501
11. Relevance of latent TB infection in areas of high TB prevalence. Sharma SK, Mohanan S, Sharma A, Chest 2012 142 761 773 10.1378/chest.1377476 22948580
12. Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. Lewinsohn DA, Zalwango S, Stein CM, Mayanja-Kizza H, Okwera A, Boom WH, Mugerwa RD, Christopher C, PLoS ONE 2008 3 3407 10.1371/journal.pone.0003407 18923705
13. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Diel R, Loddenkemper R, Neinhaus A, Chest 2012 142 63 75 Doi: 10.1378/chest.11-3157 10.1378/chest.1380697 22490872
14. Comparison of Mantoux and QuantiFERON TB Gold Tests for Diagnosis of Latent Tuberculosis Infection in Army Personnel. Franken WPJ, Timmermans JF, Prins C, Slootman EJ, Dreverman J, Bruins H, Van Dissel JT, Arend SM, J Clin Vac Immunol 2007 14 477 480 10.1128/CVI.00463-06 (Pubitemid 46732561)
15. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo G, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D, Eur Respir J 2011 37 88 99 10.1183/09031936.00115110 21030451
16. Clinical application and limitations of interferon-γ release assays for the diagnosis of latent tuberculosis infection. Herrera V, Perry S, Parsonnet J, Banaei N, Clin Infect Dis 2011 52 1031 1037 10.1093/cid/cir068 21460320
17. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D, Eur Respir J 2011 37 100 111 10.1183/09031936.00114810 20847080
18. Comparison of a new specific blood test and the skin test in tuberculosis contacts. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P, Am J Respir Crit Care Med 2004 170 65 69 10.1164/rccm.200402-232OC 15087297 (Pubitemid 38997753)
19. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. Carvalho AC, Pezzoli MC, El-Hamad I, Arce P, Bigoni S, Scarcella C, Indelicato AM, Scolari C, Carosi G, Matteelli A, J Infect 2007 55 164 168 10.1016/j.jinf.2007.02.004 17428542 (Pubitemid 47029746)
20. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T, Respir Res 2006 7 77 10.1186/1465-9921-7-77 16707012 (Pubitemid 43959902)
21. Comparison of tuberculin skin test and interferon gamma assay for the diagnosis latent tuberculosis. Poorhasan A, Haghdoost M, Mashrabi O, Am J Infect Dis 2010 2010 6 50 53
22. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in study populations. Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, Bishai WR, Clin Infect Dis 2002 34 1449 1456 10.1086/340397 12015690 (Pubitemid 34553703)
23. Latent tuberculosis diagnosis in children by using the quantiFERON-TB Gold In-Tube test. Lighter J, Rigaud M, Eduardo R, Peng C, Pollack H, Pediatrics 2009 123 30 37 10.1542/peds.2007-3618 19117857
24. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-Mycobacterium bovis BCG-vaccinated Malawian young adults. Black GF, Weir RE, Chaguluka SD, Warndorff D, Crampin AC, Mwaungulu L, Sichali L, Floyd S, Bliss L, Jarman E, Donovan L, Andersen P, Britton W, Hewinson G, Huygen K, Paulsen J, Singh M, Prestidge R, Fine PE, Dockrell HM, Clin Diagn Lab Immunol 2003 10 602 611 12853392 (Pubitemid 36890444)
25. Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacteriumtuberculosis infection. Fietta A, Meloni F, Cascina A, Morosini M, Marena C, Troupioti P, Mangiarotti P, Casali L, Am J Infect Control 2003 31 347 353 10.1016/S0196-6553(02)48240-5 14608301 (Pubitemid 37222811)
26. Direct costs of three models for the screening of latent tuberculosis infection. Wrighton-Smith P, Zellweger JP, Eur Respir J 2006 28 45 50 10.1183/09031936.06.00005906 16611659 (Pubitemid 44914259)
27. Comparison of Mantoux skin test with three generations of a whole blood IFN-γ assay for tuberculosis infection. Mahomed H, Hughes EG, Hawkridge T, Minnies D, Simon E, Little F, Hanekom WA, Geiter L, Hussey GD, IJTLD 2006 10 310 316
28. Interferon-γ release assay among tuberculin skin test positive students in Korean High Schools. Park YK, Lee SH, Kim SY, Ryoo SW, Kim CK, Kim HJ, Cho EH, Yoo BH, Lee J, Ko W, Tuber Respir Dis 2010 68 328 333 10.4046/trd.2010.68.6.328
29. The use of interferon- γ based blood tests for the detection of latent tuberculosis infection. Davies PDO, Drobniewski F, Eur Respir J 2006 28 1 3 10.1183/09031936.06.00047606 16816343 (Pubitemid 44914251)
30. Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis. Diel R, Wrighton-Smith P, Zellweger JP, Eur Respir J 2007 30 321 332 10.1183/09031936.00145906 17504793 (Pubitemid 47194185)
31. Tuberculin Skin Test. Chadha VK, Indian J Pediatr 2001 68 53 58 10.1007/BF02728860 11237237
32. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Brock I, Munk ME, Kik-Jensen A, Andersen P, Int J Tuberc Lung Dis 2001 5 462 467 11336278 (Pubitemid 32397571)
33. Yield of QuantiFERON-TB gold in tube assay and tuberculin skin test in healthy persons from a tuberculosis endemic population. Kabeer BSA, Perumalb V, Paramasivamc P, Rajaa A, J Pediatr Infect Dis 2011 5 125 129
34. Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test. Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F, BMC Infect Dis 2011 11 89 10.1186/1471-2334-11-89 21477326